Misfeldt Dayton 4
4 · SUNESIS PHARMACEUTICALS INC · Filed Apr 2, 2020
Insider Transaction Report
Form 4
Misfeldt Dayton
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2020-03-31+480,000→ 480,000 totalExercise: $0.41Exp: 2030-03-31→ Common Stock (480,000 underlying)
Footnotes (1)
- [F1]The option vests monthly over six (6) months from the date of grant subject to the optionee's continued service to the Company.